Anders Hove, M.D. Partner Office: New York Email Anders Education M.Sc., Biotechnology Engineering, Technical University of Denmark M.D., University of Copenhagen M.B.A., INSEAD

Anders has been with Venrock since 2004, applying his extensive knowledge in both venture capital and pharmaceutical operations to biotechnology companies at all stages. His experience in executive positions with the medical, clinical and business operations of the pharmaceuticals division of Ciba-Geigy led to his work as the CEO of Bellevue Asset Management. At Bellevue, Anders had responsibility for managing BB Biotech, an investment company with $1.6 billion invested in public and private companies, and he led numerous transactions in both.

“We will work any way we can to help build our companies. We provided out-of-the-box support to Anacor Pharmaceuticals and helped advance a key licensing deal. We can help find the right target market. Whatever it takes, we will be there.”

“Anders is one of the few persons who gets the big picture/strategy and can grind on the details. His emphasis on creating a large outcome helped me focus on execution and building the organization.” 
David Perry, CEO, Anacor Pharmaceuticals